Recombinant G3 domain protein of the rat laminin-5 alpha3 chain binds to integrins on tumorogenic breast cancer cells to induce apoptosis.

Paperback (Print)
Buy New
Buy New from BN.com
$69.00
Used and New from Other Sellers
Used and New from Other Sellers
from $71.94
Usually ships in 1-2 business days
Other sellers (Paperback)
  • All (1) from $71.94   
  • New (1) from $71.94   

More About This Textbook

Overview

The extracellular matrix (ECM) is a network of proteins for holding tissues and cells together. Among the constituents of the ECM is the large molecular weight glycoprotein laminin. Laminin is predominately found in the basement membrane of tissues. Laminins are composed of alpha, beta, and gamma chains with 5 globular (G) subdomains at the carboxyl (C) terminal end of the alpha chain. Of the 12 different laminin isoforms, laminin-5 has been targeted for cancer research. Specifically, the G3 domain has been studied as the specific binding domain. Cells are able to migrate through cell surface adhesion receptors known as integrins. These heterodimeric receptors are comprised of alpha and beta subunits. Studies have demonstrated integrin alpha-3 and -6 preferentially bind to laminin-5 alpha3-chain G domains.;The G3 domain of the rat laminin-5 alpha3-chain was expressed in a prokaryotic system engineered with chaperone proteins that allow for soluble protein expression in a cold temperature (11.5°C) environment. The expressed recombinant G3 (rG3) has a predicted molecular weight (MW) of 27 kDa, which matches the approximated MW for the sequence including the histidine tag. Following expression and verification through Western Blotting, the protein was purified using chromatography.;Upon separation, adhesion and proliferation assays with rG3 were performed on three breast cancer cell lines. The breast cancer cells (MDA-MB-231, MDA-MB-435, and MCF-7) expressed various levels of the alpha-3, -6, and beta-1 integrin, as determined by flow cytometry. For all three breast cancer cell lines, rG3 demonstrated dose-dependent adhesion but an inhibitory effect on proliferation. Each cell line demonstrated morphological changes characteristic of apoptosis at 3, 6, and 12 hours of rG3 treatment. The inhibitory property of rG3 prompted determination of caspase activation. Following a 12-hour treatment with rG3, each cell line was assayed for activation of caspase-3/7, -8, and -9. In each cell line, all three caspases were activated over the levels observed in untreated breast cancer cells. Of particular interest are the elevated caspase-9 levels seen in all cell lines, resulting from altered cell signaling events post-rG3 treatment. Further signaling assays revealed altered levels of phosphorylation of the kinase Akt. Therefore, rG3 binding to cancer cells is specific for the alpha subunit, but fails to engage the beta subunit necessary for induction of cell signaling events for cell survival. This ligand binding specificity leads to reduced cell viability through specific pro-apoptotic signaling events.
Read More Show Less

Product Details

  • ISBN-13: 9781243983114
  • Publisher: BiblioLabsII
  • Publication date: 9/10/2011
  • Pages: 80
  • Product dimensions: 8.00 (w) x 10.00 (h) x 0.21 (d)

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)